Post by Elaris

Thank you to GEWINN Wirtschaftsmagazin for featuring Elaris and our mission to help prevent serious bacterial infections before they happen.   As a biotech company founded in Vienna, we are proud to be building Elaris around a clear purpose: developing next-generation bacterial vaccines that can help preserve health and quality of life for aging and medically vulnerable people.   Our lead program is focused on Clostridioides difficile, one of the most persistent healthcare-associated infections worldwide — and an area where prevention could make a meaningful difference for patients, families, and healthcare systems.   Thank you to our team, advisors, partners, and investors as we continue advancing our program toward the clinic.   Read the article here: https://lnkd.in/dkEEgmNc #biotech #vaccines #infectiousdiseases #AMR #Cdiff #startup #Vienna